首页> 外文期刊>Addictive behaviors >Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunction
【24h】

Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunction

机译:儿茶酚-O-甲基转移酶(COMT)VAL158MET在甲基苯丙胺相关的行政功能障碍中的相符/满足基因型的不利影响

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: The Val allele of the Val158Met single-nucleotide polymorphism of the catechol-o-methyltransferase gene (COMT) confers greater catabolism of dopamine (DA) in the prefrontal cortex (PFC) than the Met allele. Met/Met homozygotes typically outperform Val-carriers on tests of executive function (EF), perhaps resulting from increased DA bioavailability. Methamphetamine (METH) causes large releases of DA, which is associated with neurotoxicity and executive dysfunction in chronic METH users. We hypothesized that, contrary to its effect in non-METH-using populations, slower DA clearance conferred by Met/Met will relate to worse EF in METH users.
机译:简介:儿茶醇-O-甲基转移酶基因(COMT)的Val158met单核苷酸多态性的Val等位基因赋予了前额叶皮质(PFC)的多巴胺(DA)的更大分解代谢而不是Met等位基因。 满足/满足纯合子通常优于val-载体的执行功能(EF)的测试,可能是由于DA生物利用度增加而导致。 甲基苯丙胺(甲基)导致大的DA释放,这与慢性甲基甲基甲基药物的神经毒性和行政功能障碍有关。 我们假设,符合其在非Methe-Mopling群体中的效果,达到/欧元赋予的较慢DA间隙将与甲基用户中的较差的EF相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号